Clinical Trial Update: A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD) [Phase 2]

View source ↗

Summary

A Phase 2 study assessing tegaserod alone and in combination with omeprazole for symptomatic gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• PRILOSEC (Omeprazole magnesium)
• Zelnorm (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Symptomatic Gastroespohageal Reflux Disease | Phase 2 | Status: COMPLETED